Companies/EU/969500D8TMNB

ABIVAX

Last · Paris€81.95+2.70 (+3.41%)live · yahoo · 5h ago
Vol 105.1K ≈ 8.62M
Market cap€7.2B87.3M sh
P/E · TTM-15.3fwd -28.3 · eps -5.37 · loss
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
€60.45€139.00
Volume105.1Ksession

Issuer

Legal nameABIVAX
HQEurope (EU)
ListingEU 969500D8TMNB
ISINFR0012333284
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyEUR
Entity registrylei:969500D8TMNB184OJU95
CIK0001956827
Employees80
AddressAbivax SA 7-11 Boulevard Haussmann 75009, Paris +33 1 53 83 09 63
Loading chart…

OpenFilings analyst

Our analyst

ANNUAL · 2025-04-15

From latest ANNUAL · 2025-04-15

  • Operating Cf Burn
  • Cash Runway Low

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Cash Runway Low — Cash runway ~0.9 years

Press & signals

3 of 7 recent
  • GlobeNewswire

    Abivax Presents Business Updates and First Half 2026 Financial Results

  • GlobeNewswire

    Abivax Announces Closing of $920 Million Public Offering

  • GlobeNewswire

    Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
2026-10-152026-10-150
2026-10-152026-10-150
2026-10-152026-10-150
2026-10-142026-10-140
2026-10-142026-10-140